miR-6553-3p regulates proliferation and differentiation of chicken myoblasts by targeting FAIM through the PI3K/AKT signaling pathway Authors: Zhi Hu, Longge Guo, Hengyong Xu, Ting Yang, Jiapeng Chen, Shiyu Yang, Yiping Liu, Yan Wang Published: 2026 ABSTRACT Postnatal skeletal muscle growth in poultry relies on the precise orchestration of skeletal muscle satellite cell (SMSC) fate, yet the regulatory non-coding RNA networks governing this process remain partially veiled. Integrating small RNA sequencing with developmental expression profiling, we identified miR-6553-3p as a key differentially expressed regulator. Functional assays showed that miR-6553-3p markedly reduced SMSC proliferation while promoting myogenic differentiation. Specifically, miR-6553-3p significantly suppressed PAX7 expression at both the mRNA and protein levels, while simultaneously upregulating the mRNA and protein levels of MYOG and MYH1. Mechanistically, dual-luciferase assays confirmed that miR-6553-3p directly targeted Fas Apoptotic Inhibitory Molecule (FAIM). As an indispensable regulator of cellular homeostasis and cell fate decisions, FAIM is known to modulate key signaling cascades such as PI3K/AKT. In this study, we showed that FAIM normally sustained the proliferative pool of SMSCs; however, its repression by miR-6553-3p effectively attenuated AKT phosphorylation, linking this miRNA specifically to the PI3K/AKT pathway. By characterizing the miR-6553-3p–FAIM–AKT axis, our findings provide a molecular basis for fine-tuning muscle development and enhancing production traits during the critical early post-hatch window in the poultry industry. Introduction Poultry meat serves as a critical source of animal protein in human nutrition and holds a significant share in both global and domestic meat consumption patterns (Jin et al., 2025). Valued for its favorable nutritional profile, including moderate fat levels and high-quality protein, along with its broad culinary adaptability, chicken meat enjoys widespread consumer acceptance and is frequently utilized in varied food-processing applications. In contemporary poultry production, enhancing growth efficiency and meat yield has emerged as a primary focus as the industry transitions from an emphasis on quantitative output to a more quality-driven approach (Zhang et al., 2020). Within this framework, skeletal muscle, representing the predominant edible tissue, is regarded as the key biological determinant of carcass characteristics, meat quality, and economic value (Kokoszyński et al., 2025; Muñoz-Lapeira et al., 2025; Shen et al., 2020). Consequently, deciphering the molecular mechanisms that regulate skeletal muscle development is essential for advancing genetic selection and supporting sustainable evolution of the poultry sector. Postnatal muscle growth relies fundamentally on myoblast expansion and subsequent differentiation, processes through which mononuclear progenitors fuse into multinucleated myotubes and ultimately mature into functional muscle fibers (Wang et al., 2025). A deeper understanding of the regulatory networks governing these cellular events in chicken myoblasts is therefore vital for advancing muscle accretion and refining broiler breeding strategies. MicroRNAs (miRNAs) are a class of endogenous non-coding RNAs, approximately 20-24 nucleotides in length, that regulate gene expression post-transcriptionally by binding to the 3′ untranslated regions (3′UTRs) of target mRNAs (Bartel, 2009). Numerous studies have established miRNAs as key regulators of skeletal myogenesis, where they fine tune the balance between cell proliferation, differentiation, and apoptosis (Yue et al., 2020). Several muscle-related miRNAs, including miR-21-5p (Zhang et al., 2021), miR-2954 (Dong et al., 2021), and miR-3525 (Yin et al., 2020) have been shown to coordinate myogenic progression by targeting transcription factors and structural regulators such as KLF3, YY1, and PDLIM3. miR-6553-3p is primarily annotated as gga-miR-6553-3p in chicken databases, with limited cross-mammalian homology, pointing to an avian-enriched miRNA. Prior work has shown that miR-6553-3p is strongly differentially expressed during chicken embryonic stem cell differentiation, implicating it in early lineage commitment (Li et al., 2022). In our preliminary profiling, miR-6553-3p also displayed muscle-associated variation between pectoral and leg tissues, supporting a potential role in chicken muscle development (Hu et al., 2026). Nevertheless, the functions of numerous avian-specific or less-studied miRNAs in poultry myogenesis remain largely unexplored. Systematic identification and functional characterization of these miRNAs are essential to uncover species-specific regulatory mechanisms underlying muscle development and to support the discovery of genetic. Fas apoptosis inhibitory molecule (FAIM), originally identified as an anti-apoptotic factor induced upon B-cell receptor activation, enhances cellular resistance to Fas-mediated apoptosis (Huo et al., 2019). Subsequent research has broadened the functional scope of FAIM, demonstrating its involvement in diverse cellular activities beyond apoptosis suppression, including stress adaptation, cell survival, and differentiation (Li et al., 2025). For instance, in neuronal contexts, FAIM exerts protective effects against Fas-induced cell death (Segura et al., 2007). The protein is also known to modulate pivotal signaling cascades, such as NF-κB and PI3K/AKT, which play integral roles in maintaining cellular equilibrium and directing cell fate decisions (Huo et al., 2010, 2016). Despite these advances in mammalian models, the function of FAIM in skeletal muscle, particularly in avian species, remains poorly characterized. Considering the close relationship between myoblast proliferation, differentiation, and survival signaling pathways, FAIM may function as a critical regulatory interface linking cellular viability to the progression of myogenesis. This study investigates the functional role of a miRNA-6553-3p in regulating the proliferation and differentiation of chicken skeletal muscle satellite cells (SMSCs). Through integrative bioinformatic screening utilizing RNAhybrid, Miranda, and Targetscan, we identified FAIM as a candidate target gene. We further examined whether miR-6553-3p influences the AKT phosphorylation via direct interaction with FAIM. Our results elucidate a novel molecular axis governing myogenesis in poultry, providing new insights into the regulatory mechanisms of avian muscle development and suggesting potential targets for enhancing muscle production efficiency. Materials and methods Ethics statement All experimental procedures involving animals in this study were carried out in compliance with the guidelines approved by the Institutional Animal Care and Use Committee of Sichuan Agricultural University, Sichuan, China (No: 2014-18). Public miRNA-seq data acquisition and target gene prediction To identify differentially expressed miRNAs during chicken muscle development, miRNA expression data spanning one embryonic stage (embryonic day 15, E15) and two post-hatch stages (day 1, D1; day 36, D36) were retrieved from the GEO database (GSE139304). The dataset was generated from pectoralis muscle of Tibetan chickens. Tibetan chickens are an indigenous, slow-growing, dual-purpose breed. In this study, this robust, publicly available time-course dataset was utilized solely for our initial bioinformatic screening to identify fundamentally conserved miRNA expression trends governing basic avian muscle development. First, raw sequencing data were processed to remove low-quality reads (>20% bases with a mass value <30), yielding high-quality reads. Cutadapt software (Martin, 2011) was used to further remove sequencing adapters and fragments <18 nt and >30 nt in length. Subsequently, the remaining 18–30 nt clean reads were aligned against the Repbase database (http://www.girinst.org/) to exclude transfer RNA (tRNA), ribosomal RNA (rRNA), small nuclear RNA (snRNA), and small nucleolar RNA (snoRNA) using bowtie2 software with exact matches. High-quality reads were mapped to the Gallus gallus genome to identify known mature miRNAs or pre-miRNAs using the miRBase database (http://www.mirbase.org/). Differential expression analysis of miRNAs was conducted using the edgeR package, with significance thresholds set at a P < 0.05 and an absolute log2 fold change≥1. Temporal changes in miRNA expression across these stages were examined using the Short Time-series Expression Miner (STEM) tool under default settings. miR-6553-3p exhibits a dynamic trend, with its expression significantly elevated at D36. Potential mRNA targets of miR-6553-3p were predicted through an integrated computational approach employing three algorithms: Miranda (version 3.3a, http://www.microrna.org), RNAhybrid (version 2.1.2, https://bibiserv.cebitec.uni-bielefeld.de/rnahybrid), and TargetScan (version 7.0, http://www.targetscan.org/cgi-bin/targetscan/data_download.cgi?db=vert_70). Subsequently, functional enrichment analysis of predicted target genes was conducted using the Go-seq package (version 1.62.0) in R (version 4.5.2), followed by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG, http://www.genome.jp/kegg/) pathway analysis to explore their biological roles. Cell isolation and culture SMSCs were isolated from the pectoral major of 3-day-old Tianfu broilers using a protocol modified from a previously described method (Hu et al., 2021). In stark contrast to the slow-growing Tibetan chicken, the Tianfu broiler is a commercial, fast-growing breed extensively selected for rapid skeletal muscle accretion. It was specifically chosen as our in vitro functional model to validate the role of miR-6553-3p within a commercially relevant agricultural context. Briefly, harvested muscle tissue was carefully dissected to remove residual visible blood vessels, connective tissue, and bone fragments, then finely minced into approximately 1 mm3 pieces. Digestion was carried out using 0.1% collagenase type I (Sigma, MO, USA) in combination with 0.25% trypsin (Gibco, Beijing, China). The enzymatic reaction was halted by adding an equal volume of growth medium (GM), prepared with Dulbecco's Modified Eagle Medium (DMEM; Gibco, Grand Island, NY, USA) containing 10% fetal bovine serum (FBS, Gibco, Grand Island, NY, USA) and 0.2% penicillin/streptomycin (Invitrogen, Carlsbad, CA, USA). After digestion, the cell suspension was sequentially filtered through 0.075 mm and 0.02 mm mesh cell strainers, and the cells were pelleted by centrifugation at 2000 rpm for 5 min. The isolated cells were plated in 25 cm² cell culture flasks and incubated at 37°C under 5% CO₂ in a humidified incubator. Cells were maintained in GM for 2-3 days, with medium refreshed daily. Upon reaching 80%−90% confluence in GM, differentiation was induced by switching to differentiation medium (DM; DMEM supplemented with 2% horse serum; Gibco, NY, USA), which was also replaced every 24 hours. For in vitro assays, primary SMSCs were isolated from three independent animals, representing n = 3 true biological replicates. All technical replicates within an individual biological sample were averaged before statistical analysis. RNA oligonucleotides and plasmid construction MiRNA mimics and inhibitors targeting gga-miR-6553-3p, along with their corresponding negative controls (si-NC and si-FAIM), were custom synthesized by GenePharma (Shanghai, China). The specific gga-miR-6553-3p primers were designed based on the mature sequence obtained from miRBase and synthesized utilizing the stem-loop method for highly specific reverse transcription and amplification. For FAIM overexpression, the coding sequence was cloned into the EcoRI and Xhol restriction site of the pcDNA3.1 vector (Promega, Madison, WI, USA) to generate pcDNA3.1-FAIM. The specific sequences of all oligonucleotides and constructs are provided in Supplementary Table S1. Transfections were carried out with Lipofectamine 3000 (Invitrogen, Cat. No. L3000150) in Opti-MEM medium (Gibco, Cat. No. 31985070 when cells attained 50-60% confluence. Following transfection, cells were cultured under standrad conditions (37°C, 5% CO₂) and collected 24 to 48 hours later for subsequent RNA and protein analysis. Dual-luciferase reporter assay The putative binding sites of miR-6553-3p within the FAIM 3′ UTR were identified using the RNAhybrid algorithm. Corresponding Wild-type (WT) and mutant (MUT) fragment of the FAIM 3′ UTR were subsequently cloned into dual-luciferase reporter vectors (GeneCreate, Wuhan, China). These constructs were co-transfected into SMSCs using lipofectamine 3000 alongside either the miR-6553-3p mimic or its negative control (mimic-NC). After 24-48 hours, luciferase activity was quantified using a dual-luciferase assay kit (Beyotime, Shanghai, China) with a multimode microplate reader (PerkinElmer, Germany). RNA extraction and Real-time quantitative PCR (RT-qPCR) Total RNA was isolated from SMSCs at 24 h post-transfection with TRIzol reagent (Invitrogen, Carlsbad, CA, USA). Complementary DNA for mRNA and miRNA analysis was synthesized separately using the Prime Script RT Kit and the One-Step miRNA Synthesis Kit (Takara, Dalian, China), respectively. Quantitative PCR was then performed with SYBR Green Premix (Takara, Dalian, China) on a Light Cycler 480 II system (Roche, Switzerland) at an annealing temperature of 60°C. Gene expression was normalized to GAPDH (for mRNA) and U6 small nuclear RNA (for miRNA). Relative quantification was carried out using the 2−ΔΔCt method. All primer sequences used in this study are provided in Supplementary Table S2. Cell counting Kit-8 (CCK-8) assay Cell proliferation was assessed with a Cell Counting Kit-8 (CCK-8; Vazyme, Nanjing, China). Following transfection, cells were treated with the CCK-8 reagent at 0, 24, 48, and 72 h, followed by a 2 h incubation at 37°C. Absorbance at 450 nm was recorded using a multimode microplate reader (PerkinElmer, Germany) to determine cell viability. 5-Ethynyl-2′-deoxyuridine (EdU) assay SMSCs were transfected with either miR-6553-3p mimic, its negative control mimic (mimic-NC), the corresponding inhibitor, or its inhibitor control (inhibitor-NC). At 48 h post-transfection, cell proliferation was evaluated using the Cell-Light™ EdU Apollo in vitro kit (RiboBio, Guangzhou, China), following the manufacturer’s protocol. Images were captured from three randomly selected fields per condition under an inverted fluorescence microscope (Leica DMi8, Germany). The proportion of EdU-positive cells was subsequently determined using ImageJ software. Protein extraction and western blotting Chicken SMSCs were plated uniformly in six-well plates. At 48 hours after transfection, cells in each well were lysed with 200 μL of lysis buffer. Following 30 minutes of lysis on ice, the supernatant was collected. Protein concentration was quantified using a BCA Protein Assay Kit (Vazyme, China), and samples were normalized to equal concentrations. Subsequently, proteins were denatured by heating at 98°C for 10 minutes in 5×SDS-PAGE loading buffer (Solarbio, China). Equal amounts of protein (15 μL per lane) were loaded onto SDS-polyacrylamide gels. Electrophoresis was initiated at 80 V for 30 minutes, followed by an increase to 120 V until clear band separation was achieved. Proteins were then transferred onto PVDF membranes at a constant current of 200 mA for 2 hours. Membranes were blocked with 5% non-fat milk for 1hat room temperature to prevent non-specific binding. After blocking, membranes were incubated at 4°C with primary antibodies diluted in blocking solution. The primary antibodies used were: anti-PAX7 (1:2000; A7335, ABclonal, China), anti-MYH1 (1:2000; Proteintech, China), anti-MYOG (1:2000; A17427, ABclonal, China), anti-FAIM (1:2000; Proteintech, China), anti-AKT (1:2000; Proteintech, China), anti-P-AKT (1:2000; Proteintech, China), anti-PI3K (1:2000; Abmart, China), anti-P-PI3K (1:2000; Abmart, China) and anti-β-tubulin (1:5000; AC021, ABclonal, China). Following primary antibody incubation, membranes were washed three times with 1×TBST (Solarbio, China) and then incubated for 1 h at room temperature with HRP-conjugated goat anti-rabbit IgG (1:5000; Beyotime, China) or goat anti-mouse IgG (1:5000; Beyotime, China) secondary antibodies. as appropriate. Protein bands were visualized using enhanced chemiluminescence (ECL) substrate (Vazyme, China) on a chemiluminescence imaging system (Tanon, China). Band intensities were quantified using ImageJ software. Immunofluorescence (IF) Chicken SMSCs were seeded in 12-well plates. Upon reaching approximately 90% confluence, differentiation was initiated by the addition of horse serum. After 72 h post-transfection, cells were fixed with 4% paraformaldehyde for 30 min and permeabilized with 0.5% Triton X-100 for 15 min at room temperature. Non-specific binding sites were blocked by incubation with 5% bovine serum albumin (BSA) for 30 min. After blocking, cell were incubated at 4°C with primary antibodies against MYH1 (25182-1-AP, Proteintech, China) and PAX7 (20570-1-AP, Proteintech, China). Following primary antibody incubation, cells were incubated with Rhodamine (TRITC)-conjugated Goat anti-Rabbit IgG (H+L) (AS040, ABclonal, China) for 1 hour at 37°C. Cell nuclei were subsequently counterstained with DAPI for 3-5 minutes. For each treatment condition, three randomly selected fields were imaged. Myotube area was quantified using ImageJ software. Flow cytometry analysis of cell cycle For cell cycle analysis, SMSCs were transfected upon reaching 60-70% confluence. Forty-eight hours post-transfection, cells were harvested and fixed overnight in pre-chilled 75% ethanol at 4°C. The fixed cells were then stained with propidium iodide (PI, 50 µg/mL; Beyotime, Shanghai, China) for 30 min at room temperature in the dark. Cellular DNA content was measured on a BD FACSCanto II flow cytometer (BD Biosciences, USA), and cell cycle distribution was analyzed using FlowJo v10 software. All experiments were performed in at least three independent replicates. Statistical analyses All statistical analyses were performed using SPSS 17.0 (SPSS, Inc., Chicago, IL, USA). Prior to significance testing, the normal distribution of the data was verified using the Shapiro-Wilk test, and variance homogeneity was assessed via Levene’s test. Data are presented as means value with standard deviations (SD). Comparisons between two groups were conducted using an unpaired two-tailed Student’s t-test, while comparisons among multiple groups were evaluated by one-way analysis of variance (ANOVA). Differences were considered statistically significant at P < 0.05 (* P < 0.05; ** P < 0.01, *** P < 0.001). Results MiRNA screening Heatmap visualization of miRNA-seq data across embryonic day 15 (E15), post-hatch day 1 (D1), and day 36 (D36) delineated stage-specific expression patterns of miRNAs during chicken muscle development (Fig. 1A). STEM trend analysis assigned the differentially expressed miRNAs to eight temporal profiles, of which four colored profiles (0, 1, 3, and 4) met the significance criteria (Fig. 1B). The constituent miRNAs of these significant profiles are listed in Table S3. From the candidate miRNAs defined by these trends, miR-6553-3p was selected for cellular validation. RT-qPCR results revealed no difference in its expression levels between the E15 and D1 stages, but a significant upregulation occurred at the D36 stage (Fig. 1C). Furthermore, successful isolation of primary SMSCs was validated by positive immunofluorescence staining for the satellite cell marker PAX7 (Fig. 1D), thereby establishing a robust cellular system for downstream functional studies.Fig. 1Screening and functional validation of miRNAs. (A) Expression profiles of differentially expressed miRNAs in chicken skeletal muscle at embryonic day 15 (E15), 1-day post-hatch (D1), and day 36 (D36). (B) Trend analysis of miRNAs expression patterns across developmental stages. The numbers 0-7 in the upper left corner of the 8 blocks correspond to 8 distinct expression trends. Colored blocks represent miRNAs with statistically significant trend changes, while uncolored blocks denote miRNAs with non-significant trends. (C) Relative expression level of miR-6553-3p measured by RT-qPCR at E15, D1 and D36 (n = 3). (D) Immunofluorescence staining of PAX7 to evaluate the purity of isolated satellite cell. Data are presented as mean±SD of three independent biological replicates. NS, not significant (P > 0.05), * P < 0.05, ** P < 0.01, *** P < 0.001.Fig 1 dummy alt text Screening and functional validation of miRNAs. (A) Expression profiles of differentially expressed miRNAs in chicken skeletal muscle at embryonic day 15 (E15), 1-day post-hatch (D1), and day 36 (D36). (B) Trend analysis of miRNAs expression patterns across developmental stages. The numbers 0-7 in the upper left corner of the 8 blocks correspond to 8 distinct expression trends. Colored blocks represent miRNAs with statistically significant trend changes, while uncolored blocks denote miRNAs with non-significant trends. (C) Relative expression level of miR-6553-3p measured by RT-qPCR at E15, D1 and D36 (n = 3). (D) Immunofluorescence staining of PAX7 to evaluate the purity of isolated satellite cell. Data are presented as mean±SD of three independent biological replicates. NS, not significant (P > 0.05), * P < 0.05, ** P < 0.01, *** P < 0.001. MiR-6553-3p inhibits proliferation of chicken SMSCs RT-qPCR confirmed transfection efficiency, with miR-6553-3p inhibitor treatment significantly downregulation (P < 0.01; Fig. 2A) and miR-6553-3p mimic transfection substantially upregulating its expression (P < 0.001; Fig. 2B). Subsequently functional assay revealed that miR-6553-3p overexpression suppressed the proliferation of SMSCs, whereas its inhibition promoted cell growth, as evidenced by CCK-8 analysis (P < 0.01; Fig. 2C, D). Consistent with this phenotypic observation, both RT-qPCR and western blot analyses showed that PAX7 expression was elevated upon miR-6553-3p inhibition but reduced after mimic transfection (P < 0.05; Fig. 2E–H). Cell cycle distribution assessed by flow cytometry further indicated that miR-6553-3p inhibition decreased the proportion of cells in G0/G1 phase while increasing the S-phase population (P < 0.01; Fig. 2I). Conversely, miR-6553-3p overexpression led to a G0/G1 arrest and a reduction in S-phase cells (P < 0.05; Fig. 2J). These results were corroborated by EdU staining, which demonstrated a higher percentage of EdU-positive nuclei following miR-6553-3p knockdown (P < 0.01; Fig. 2K) and a decrease upon its overexpression (P < 0.01; Fig. 2L). Together, these findings indicate that miR-6553-3p functions as a negative regulator of proliferation in chicken SMSCs.Fig. 2miR-6553-3p inhibits the proliferation of chicken SMSCs. (A, B) Validation of transfection efficiency: expression levels of miR-6553-3p following inhibitor or mimic treatment (n = 3). (C, D) Proliferation of SMSCs after transfection with miR-6553-3p inhibitor or mimics, as assessed by CCK-8 assay (n = 3). (E, F) Effects of miR-6553-3p inhibitor or mimics on the expression of PAX7 mRNA and PAX7 protein. (n = 3). (I, J) Cell cycle distribution of SMSCs transfected with miR-6553-3p inhibitor or mimics, analyzed by flow cytometry. Proportion of cell in G0/G1, S, and G2/M phases are shown (n = 3). (K, L) EdU staining of SMSCs after transfection with miR-6553-3p inhibitor or mimics. Cells in S-phase are labeled with EdU (red), nuclei are counterstained with DAPI (blue), and EdU-positive cells were quantified using Image J. Scale bar: 200 μm (n = 3). Data are presented as mean±SD of three independent biological replicates. NS, not significant (P > 0.05), * P < 0.05, ** P < 0.01, *** P < 0.001.Fig 2 dummy alt text miR-6553-3p inhibits the proliferation of chicken SMSCs. (A, B) Validation of transfection efficiency: expression levels of miR-6553-3p following inhibitor or mimic treatment (n = 3). (C, D) Proliferation of SMSCs after transfection with miR-6553-3p inhibitor or mimics, as assessed by CCK-8 assay (n = 3). (E, F) Effects of miR-6553-3p inhibitor or mimics on the expression of PAX7 mRNA and PAX7 protein. (n = 3). (I, J) Cell cycle distribution of SMSCs transfected with miR-6553-3p inhibitor or mimics, analyzed by flow cytometry. Proportion of cell in G0/G1, S, and G2/M phases are shown (n = 3). (K, L) EdU staining of SMSCs after transfection with miR-6553-3p inhibitor or mimics. Cells in S-phase are labeled with EdU (red), nuclei are counterstained with DAPI (blue), and EdU-positive cells were quantified using Image J. Scale bar: 200 μm (n = 3). Data are presented as mean±SD of three independent biological replicates. NS, not significant (P > 0.05), * P < 0.05, ** P < 0.01, *** P < 0.001. MiR-6553-3p promotes differentiation of chicken SMSCs RT-qPCR analysis showed that inhibition of miR-6553-3p significantly downregulated the mRNA levels of key myogenic differentiation markers, including MYOD1, MYOG, and MYH1 (P < 0.05; Fig. 3A). Consistently, western blotting revealed reduced MYOG and MYH1 protein expression following miR-6553-3p inhibition (P < 0.05; Fig. 3B). In contrast, overexpression of miR-6553-3p significantly increased the transcript levels of MYOD1, MYOG, and MYH1 (P < 0.05; Fig. 3C) and elevated MYOG and MYH1 protein abundance (P < 0.05; Fig. 3D). Immunofluorescence staining for myotube formation further supported these findings, showing impaired myotube differentiation after miR-6553-3p knockdown, whereas its overexpression significantly enhanced the formation and maturation of myotubes (P < 0.01; Fig. 3E, F). Collectively, these results indicate that miR-6553-3p plays a positive regulatory role in the differentiation of chicken SMSCs.Fig. 3miR-6553-3p promotes differentiation of chicken SMSCs. (A, C) Effects of miR-6553-3p inhibitor and mimics on the mRNA expression of differentiation-related genes (n = 3). (B, D) Protein expression levels of the differentiation markers MYOG and MYH1 in SMSCs following transfection with miR-6553-3p inhibitor or mimics (n = 3). (E, F) Myogenic differentiation of SMSCs transfected with miR-6553-3p inhibitor or mimics assessed by immunofluorescence staining. Myotubes were labeled with MYH1 (red), nuclei were counterstained with Hoechst (blue), and myotube area was quantified using Image J. Scale bar: 100 μm (n = 3). Data are presented as mean±SD of three independent biological replicates. NS, not significant (P > 0.05), * P < 0.05, ** P < 0.01, *** P < 0.001.Fig 3 dummy alt text miR-6553-3p promotes differentiation of chicken SMSCs. (A, C) Effects of miR-6553-3p inhibitor and mimics on the mRNA expression of differentiation-related genes (n = 3). (B, D) Protein expression levels of the differentiation markers MYOG and MYH1 in SMSCs following transfection with miR-6553-3p inhibitor or mimics (n = 3). (E, F) Myogenic differentiation of SMSCs transfected with miR-6553-3p inhibitor or mimics assessed by immunofluorescence staining. Myotubes were labeled with MYH1 (red), nuclei were counterstained with Hoechst (blue), and myotube area was quantified using Image J. Scale bar: 100 μm (n = 3). Data are presented as mean±SD of three independent biological replicates. NS, not significant (P > 0.05), * P < 0.05, ** P < 0.01, *** P < 0.001. MiR-6553-3p targets the FAIM gene Integrative target prediction employing RNAhybrid, miRanda, and TargetScan identified 1,302 potential target transcripts corresponding to 567 genes for miR-6553-3p. KEGG pathway enrichment analysis of these predicted target genes revealed significant involvement in pathways associated with cell growth and signal transduction (Fig. 4A). GO analysis further indicated that the target genes were predominantly enriched in biological processes related to cellular regulation, as well as molecular functions including catalytic activity and signal transducer activity (Fig. 4B; full results in Table S3). Among the candidate targets, FAIM was selected for further validation based on its functional relevance and a favorable predicted binding energy. RNAhybrid analysis indicated a minimum free energy of −20.6 kcal/mol for the interaction between miR-6553-3p and the 3′UTR of FAIM, suggesting a stable hybrid. Accordingly, dual-luciferase reporter vectors containing either the wild-type (FAIM-WT) or a mutated (FAIM-MT) binding site within the FAIM 3′ UTR were constructed (Fig. 4C). Transfection with the miR-6553-3p mimic significantly reduced luciferase activity in cells expressing the FAIM-WT reporter, whereas this suppressive effect was abrogated in the FAIM-MT control (P < 0.05; Fig. 4D). Supporting this interaction, RT-qPCR and Western blot analyses demonstrated that inhibition of miR-6553-3p upregulated both FAIM mRNA and protein levels, while its overexpression downregulated FAIM expression (P < 0.01; Fig. 4E-G). Furthermore, to establish the spatiotemporal context of FAIM function, we assessed its expression profile. RT-qPCR analysis revealed that FAIM expression dynamically fluctuates during breast muscle development (E15, D1, and D36) and exhibits a significant, time-dependent downregulation during the in vitro differentiation of chicken SMSCs (Fig. S1A-B). Collectively, these results establish FAIM as a direct functional target of miR-6553-3p in chicken SMSCs, suggesting that it may be involved in regulating the proliferation and differentiation.Fig. 4miR-6553-3p directly targets FAIM. (A) KEGG pathway enrichment analysis of 567 potential target genes predicted for miR-6553-3p through bioinformatic databases. (B) Gene Ontology (GO) enrichment distribution of predicted miR-6553-3p target genes. (C) Schematic representation of the predicted binding site between miR-6553-3p and the 3′-UTR of FAIM. (D) Dual-luciferase reporter activity in cells transfected with miR-6553-3p mimics or negative control for 24 h (n = 3). (E, F) mRNA expression of FAIM measured by RT-qPCR 24 h after transfection with miR-6553-3p inhibitor or mimics (n = 3). (G) FAIM protein expression analyzed by western blot under the same transfection conditions (n = 3). Data are presented as mean±SD of three independent biological replicates. NS, not significant (P > 0.05), * P < 0.05, ** P < 0.01, *** P < 0.001.Fig 4 dummy alt text miR-6553-3p directly targets FAIM. (A) KEGG pathway enrichment analysis of 567 potential target genes predicted for miR-6553-3p through bioinformatic databases. (B) Gene Ontology (GO) enrichment distribution of predicted miR-6553-3p target genes. (C) Schematic representation of the predicted binding site between miR-6553-3p and the 3′-UTR of FAIM. (D) Dual-luciferase reporter activity in cells transfected with miR-6553-3p mimics or negative control for 24 h (n = 3). (E, F) mRNA expression of FAIM measured by RT-qPCR 24 h after transfection with miR-6553-3p inhibitor or mimics (n = 3). (G) FAIM protein expression analyzed by western blot under the same transfection conditions (n = 3). Data are presented as mean±SD of three independent biological replicates. NS, not significant (P > 0.05), * P < 0.05, ** P < 0.01, *** P < 0.001. FAIM gene promotes proliferation of chicken SMSCs To investigate the functional role of FAIM in SMSCs, three siRNAs sequences targeting FAIM were designed along with an FAIM overexpression plasmid (OE-FAIM). Transfection efficiency was confirmed by RT-qPCR, which showed that OE-FAIM significantly upregulated FAIM expression, while siRNA1 exhibited the highest knockdown efficiency and was therefore selected for subsequent functional assays (P < 0.001; Fig. 5A). Knockdown of FAIM led to a significant reduction in both PAX7 mRNA and PAX7 protein levels, whereas FAIM overexpression resulted in a marked increase (P < 0.05; Fig. 5B, C). In functional proliferation assays, CCK-8 analysis demonstrated that FAIM inhibition suppressed SMSCs growth, while FAIM overexpression significantly enhanced cellular proliferation (P < 0.001; Fig. 5D). These observations were further supported by EdU staining, which showed a decreased proportion of EdU-positive nuclei upon FAIM knockdown and a substantial increase following FAIM overexpression (P < 0.01; Fig. 5E). Cell cycle analysis via flow cytometry corroborated these findings, indicating that FAIM knockdown reduced the proportion of proliferating cell, whereas its overexpression promoted cell cycle progression (P < 0.05; Fig. 5F). Together, these results demonstrate that FAIM functions as a positive regulator of proliferation in chicken SMSCs.Fig. 5FAIM promotes the proliferation of chicken SMSCs. (A) Validation of transfection efficiency: expression of FAIM after siRNA-mediated knockdown or plasmid-mediated overexpression. (B) Effect of FAIM interference or overexpression on the mRNA expression of the proliferation marker PAX7. (C) Protein level of FAIM and PAX7 following FAIM interference or overexpression, assessed by western blotting (n = 3). (D) Proliferation of SMSCs after FAIM interference or overexpression, measured by CCK-8 assay (n = 3). (E) EdU staining of SMSCs transfected with FAIM siRNA or overexpression plasmid. S-phase cells are labeled with EdU (red), nuclei are counterstained with DAPI (blue), and EdU-positive cells were quantified using Image J. Scale bar: 200 μm (N = 3). (F) Cell cycle distribution of SMSCs following FAIM knockdown or overexpression, analyzed by flow cytometry. Percentages of cell in G0/G1, S, and G2/M phases are shown (n = 3). Data are presented as mean±SD of three independent biological replicates. NS, not significant (P > 0.05), * P < 0.05, ** P < 0.01, *** P < 0.001.Fig 5 dummy alt text FAIM promotes the proliferation of chicken SMSCs. (A) Validation of transfection efficiency: expression of FAIM after siRNA-mediated knockdown or plasmid-mediated overexpression. (B) Effect of FAIM interference or overexpression on the mRNA expression of the proliferation marker PAX7. (C) Protein level of FAIM and PAX7 following FAIM interference or overexpression, assessed by western blotting (n = 3). (D) Proliferation of SMSCs after FAIM interference or overexpression, measured by CCK-8 assay (n = 3). (E) EdU staining of SMSCs transfected with FAIM siRNA or overexpression plasmid. S-phase cells are labeled with EdU (red), nuclei are counterstained with DAPI (blue), and EdU-positive cells were quantified using Image J. Scale bar: 200 μm (N = 3). (F) Cell cycle distribution of SMSCs following FAIM knockdown or overexpression, analyzed by flow cytometry. Percentages of cell in G0/G1, S, and G2/M phases are shown (n = 3). Data are presented as mean±SD of three independent biological replicates. NS, not significant (P > 0.05), * P < 0.05, ** P < 0.01, *** P < 0.001. FAIM inhibits differentiation of chicken SMSCs To further explore the regulatory function of FAIM in SMSC differentiation, we examined its effects on key differentiation markers. RT-qPCR analysis revealed that FAIM knockdown significantly elevated mRNA levels of MYOG and MYH1 (P < 0.01), while FAIM overexpression led to a notable reduction in their transcription (P < 0.05; Fig. 6A). Western blotting results corroborated these observations, showing increased MYOG and MYH1 protein expression following FAIM inhibition, and decreased expression upon FAIM upregulation (P < 0.05; Fig. 6B). Consistent with these molecular changes, immunofluorescence staining demonstrated enhanced myotube formation in FAIM-knockdown cells, whereas FAIM overexpression significantly suppressed myotube formation and reduced myotube area (P < 0.01; Fig. 6C). Taken together, these results indicate that FAIM inhibits differentiation in chicken SMSCs.Fig. 6FAIM suppresses the differentiation of chicken SMSCs. (A) Effects of FAIM interference or overexpression on mRNA expression of differentiation-related genes (n = 3). (B) Protein expression levels of the differentiation markers MYOG and MYH1 in SMSCs following FAIM interference or overexpression, as determined by western blot (n = 3). (C) Myogenic differentiation assessed by immunofluorescence staining of SMSCs transfected with FAIM siRNA or overexpression plasmid. Myotubes were stained with MYH1 (red) and nuclei were counterstained with DAPI (blue). Myotube area was quantified using Image J. Scale bar:100 μm (n = 3). Data are presented as mean±SD of three independent biological replicates. NS, not significant (P > 0.05), * P < 0.05, ** P < 0.01, *** P < 0.001.Fig 6 dummy alt text FAIM suppresses the differentiation of chicken SMSCs. (A) Effects of FAIM interference or overexpression on mRNA expression of differentiation-related genes (n = 3). (B) Protein expression levels of the differentiation markers MYOG and MYH1 in SMSCs following FAIM interference or overexpression, as determined by western blot (n = 3). (C) Myogenic differentiation assessed by immunofluorescence staining of SMSCs transfected with FAIM siRNA or overexpression plasmid. Myotubes were stained with MYH1 (red) and nuclei were counterstained with DAPI (blue). Myotube area was quantified using Image J. Scale bar:100 μm (n = 3). Data are presented as mean±SD of three independent biological replicates. NS, not significant (P > 0.05), * P < 0.05, ** P < 0.01, *** P < 0.001. MiR-6553-3p regulates proliferation and differentiation of chicken SMSCs by targeting FAIM To establish whether miR-6553-3p exerts its regulatory effects on SMSCs through FAIM, rescue experiments were performed. Following co-transfection of mimic-NC+OE-NC, mimic-NC+OE-FAIM, and mimic+OE-FAIM, RT-qPCR analysis indicated that FAIM overexpression significantly upregulated PAX7 expression. However, this effect was reversed when FAIM overexpression was combined with miR-6553-3p mimics (P < 0.01; Fig. 7A), a result confirmed at the protein level by Western blot (Fig. 7B). In functional assays, CCK-8 and EdU analyses demonstrated that while FAIM overexpression promoted SMSC proliferation, this pro-proliferative effect was suppressed upon co-transfection with miR-6553-3p mimics (Fig. 7C-D). Similarly, FAIM overexpression reduced MYOG expression and impaired myotube formation, but concurrent overexpression of miR-6553-3p restored both myogenic marker expression and differentiation capacity (Fig. 7E-G). Collectively, these findings indicate that miR-6553-3p modulates the proliferation and differentiation of chicken SMSCs by directly targeting FAIM.Fig. 7miR-6553-3p regulates the proliferation and differentiation of chicken SMSCs through targeting FAIM. (A, B) PAX7 mRNA and PAX7 protein expression levels following co-transfection with OE-NC, OE-FAIM, mimic-NC, or miR-6553-3p mimic (n = 3). (C) Proportion of EdU-positive cells after co-transfection under the indicated conditions (scale bar: 200 μm, n = 3) (D) Proliferation of SMSCs measured by CCK-8 after co-transfection with miR-6553-3p mimic and FAIM overexpression plasmid (n = 3). (E, F) MYOG mRNA and MYOG protein expression levels after co-transfection as described above (n = 3). (G) Myogenic differentiation evaluated by immunofluorescence staining following co-transfection. Myotubes were stained with MYH1 (red), nuclei were counterstained with DAPI (blue), and myotube area was quantified using ImageJ (scale bar: 200 μm, n = 3). Data are presented as mean±SD of three independent biological replicates. NS, not significant (P > 0.05), * P < 0.05, ** P < 0.01, *** P < 0.001.Fig 7 dummy alt text miR-6553-3p regulates the proliferation and differentiation of chicken SMSCs through targeting FAIM. (A, B) PAX7 mRNA and PAX7 protein expression levels following co-transfection with OE-NC, OE-FAIM, mimic-NC, or miR-6553-3p mimic (n = 3). (C) Proportion of EdU-positive cells after co-transfection under the indicated conditions (scale bar: 200 μm, n = 3) (D) Proliferation of SMSCs measured by CCK-8 after co-transfection with miR-6553-3p mimic and FAIM overexpression plasmid (n = 3). (E, F) MYOG mRNA and MYOG protein expression levels after co-transfection as described above (n = 3). (G) Myogenic differentiation evaluated by immunofluorescence staining following co-transfection. Myotubes were stained with MYH1 (red), nuclei were counterstained with DAPI (blue), and myotube area was quantified using ImageJ (scale bar: 200 μm, n = 3). Data are presented as mean±SD of three independent biological replicates. NS, not significant (P > 0.05), * P < 0.05, ** P < 0.01, *** P < 0.001. MiR-6553-3p modulates the PI3K/AKT signaling pathway by targeting FAIM Given that FAIM has been implicated in multiple signaling cascades, including the PI3K/AKT pathway, we next investigated whether miR-6553-3p and FAIM modulate PI3K and AKT activation in SMSCs. Overexpression of miR-6553-3p led to a significant decrease in phosphorylated PI3K (P-PI3K) and phosphorylated AKT (P-AKT) levels without altering total PI3K or AKT expression (Fig. 8A). Conversely, FAIM overexpression substantially enhanced both P-PI3K and P-AKT levels (Fig. 8B). In rescue experiments, co-transfection of miR-6553-3p mimics with OE-FAIM abrogated the FAIM-induced increase in P-PI3K and P-AKT (Fig. 8C), demonstrating that miR-6553-3p suppresses the PI3K/AKT signaling cascade through its direct target FAIM. These findings indicate that the regulatory effect of miR-6553-3p on SMSCs proliferation and differentiation is mediated, at least in part, via the FAIM-dependent modulation of the PI3K/AKT pathway.Fig. 8miR-6553-3p modulates the PI3K/AKT signaling pathway by targeting FAIM. (A-C) Western blot analysis of P-AKT/AKT and P-PI3K/PI3K expression in SMSCs transfected with miR-6553-3p mimic or OE-FAIM. Corresponding quantitative data of protein levels are displayed in the adjacent panels. Data are presented as mean±SD of three independent biological replicates. NS, not significant (P > 0.05), * P < 0.05, ** P < 0.01, *** P < 0.001.Fig 8 dummy alt text miR-6553-3p modulates the PI3K/AKT signaling pathway by targeting FAIM. (A-C) Western blot analysis of P-AKT/AKT and P-PI3K/PI3K expression in SMSCs transfected with miR-6553-3p mimic or OE-FAIM. Corresponding quantitative data of protein levels are displayed in the adjacent panels. Data are presented as mean±SD of three independent biological replicates. NS, not significant (P > 0.05), * P < 0.05, ** P < 0.01, *** P < 0.001. Discussion In this study, we define miR-6553-3p as a key modulator of proliferation and differentiation in chicken SMSCs. Our results show that miR-6553-3p directly suppresses FAIM expression, thereby attenuating Akt signaling, which in turn inhibits cell inhibiting proliferation and enhances myogenic differentiation. The development of skeletal muscle depends on the controlled shift of SMSCs from a PAX7-positive, proliferative state into terminal differentiation (Chen et al., 2025). Although miR-6553-3p, a member of the miR-6553 family, has been linked to chicken embryonic development (Li et al., 2023), its specific function in myogenesis remains unclear. In our preliminary research, we found that miR-6553-3p exhibits significant differential expression in chicken breast and thigh muscles. In this work, we found that ectopic expression of miR-6553-3p reduced PAX7 levels, a transcription factor essential for maintaining the proliferative capacity of muscle stem cells (Qi et al., 2023). Furthermore, we examined its influence on differentiation markers such as MYOG and MYH1. Given that the muscle regulatory factor (MRF) family-including MYOD, MYF5, MYOG, and MYF6 orchestrates the myogenic differentiation program (Choe et al., 2025; Xiong et al., 2024; Zhou et al., 2024), our data indicate that miR-6553-3p facilitates the transition of SMSCs from a PAX7-dependent proliferative phase towards a differentiated state, thereby coordinately regulating both proliferation and differentiation. Functionally, this “anti-proliferative yet pro-differentiation” profile is consistent with a fate-switch regulator and may help explain muscle-group growth heterogeneity in poultry. We further identified FAIM as a key downstream effector of miR-6553-3p in SMSCs. FAIM is a recognized anti-apoptotic protein known to interact with the Fas receptor and related signaling components, thereby inhibiting Fas-mediated apoptosis and supporting cell survival and proliferation (Segura et al., 2007). Recent studies further indicate that FAIM contributes to the regulation of survival-associated signaling networks (Feng et al., 2024; Wang et al., 2013, 2020). However, its function in skeletal muscle remained unclear. This study reveals that FAIM promotes proliferation and inhibits differentiation in satellite muscle cells (SMSCs), suggesting it helps maintain cellular proliferation and survival during myogenesis. The inhibition of FAIM by miR-6553-3p constitutes a critical molecular node regulating satellite cell fate. The PI3K/AKT signaling pathway plays a crucial role in cell proliferation and differentiation. Phosphorylation of Akt promotes the translocation of the insulin-responsive glucose transporter Glut-4 from intracellular vesicles to the plasma membrane, enhancing cellular glucose uptake. Impaired Akt activity in skeletal muscle is associated with systemic glucose intolerance and insulin resistance, underscoring its essential role in muscle growth and metabolic regulation (Jaiswal et al., 2019; Wang et al., 2026; Yue et al., 2026; Zhang et al., 2026). Muscle-specific Akt1/2 knockout mice display severe muscle atrophy, reduced strength, and insulin resistance, along with a near-complete absence of insulin-stimulated Akt phosphorylation (Roberts et al., 2023; Sasako et al., 2022). A growing body of research indicates that FAIM also supports cell proliferation and metabolic homeostasis by promoting PI3K/Akt signaling activation (Feng et al., 2024; Han et al., 2022; Huo et al., 2013). Consistent with this, miR-6553-3p-mediated downregulation of FAIM significantly reduced both PI3K and AKT phosphorylation levels, prompting cells to exit the cell cycle and activate myogenic differentiation programs. This establishes the functional role of the FAIM–PI3K/AKT axis in SMSCs. It is imperative to acknowledge that our functional assays were conducted using SMSCs isolated from 3-day-old broilers. This early post-hatch period represents a phase of elevated epigenetic plasticity and permissive chromatin organization. Therefore, the miR-6553-3p-FAIM axis we describe primarily models early developmental dynamics. The regulatory balance of proliferation and differentiation could inherently differ at later post-hatch stages as non-coding RNA networks, DNA methylation patterns, and chromatin accessibility become more strictly established. Notably, in rescue experiments, FAIM overexpression only partially restored the differentiation phenotype, which may be related to both the efficiency of overexpression and the complexity of the miRNA regulatory network (Hao et al., 2019). miRNAs often simultaneously target multiple genes, and intervention at a single target site struggles to fully replicate the overall regulatory effects of miRNAs(DeVeale et al., 2021; Krol et al., 2010). Moreover, although we have demonstrated that miR-6553-3p targets FAIM and suppresses the phosphorylation of both PI3K and AKT, further in-depth validation using specific PI3K/AKT inhibitors or activators is warranted to fully establish the necessity of this cascade. Future studies should employ such inhibition and rescue designs, combined with detection of key downstream effectors (such as mTOR, GSK3β, and FOXO phosphorylation), to validate this mechanism. Although FAIM is a key functional target gene of miR-6553-3p, other potential targets and their synergistic interactions warrant further investigation. From an applied perspective, the miR-6553-3p-FAIM regulatory axis provides novel molecular targets for improving poultry muscle traits. Moderately enhancing miR-6553-3p activity without disrupting overall muscle homeostasis, or specifically inhibiting FAIM/AKT signaling, may enhance myofibrillar formation efficiency. This approach could consequently improve growth performance and production efficiency in broiler chickens. Conclusion This study identifies miR-6553-3p as a critical regulator of both proliferation and differentiation in chicken SMSCs during early post-hatch development. Functionally, miR-6553-3p suppresses cell proliferation while promoting myotube formation, mediated through direct targeting of FAIM and consequent modulation of AKT phosphorylation (Fig. 9). These results delineate a previously unrecognized miR-6553-3p–FAIM–AKT regulatory axis involved in poultry skeletal muscle development, offering potential molecular targets for genetic improvement of muscle traits in chickens.Fig. 9Proposed mechanism by which miR-6553-3p regulates proliferation and differentiation of chicken SMSCs.Fig 9 dummy alt text Proposed mechanism by which miR-6553-3p regulates proliferation and differentiation of chicken SMSCs. Data availability The original contributions presented in the study are included in the article, further inquiries can be directed to the corresponding author. Consent for publication Not applicable. Funding This research was supported by 10.13039/501100010250Sichuan Province innovation team project (SCCXTD-2026-26). CRediT authorship contribution statement Zhi Hu: Writing – original draft, Validation, Resources, Conceptualization. Longge Guo: Validation, Resources, Conceptualization. Hengyong Xu: Writing – review & editing, Conceptualization. Ting Yang: Validation, Resources. Jiapeng Chen: Validation, Resources. Shiyu Yang: Resources. Yiping Liu: Resources. Yan Wang: Writing – review & editing, Funding acquisition, Conceptualization. Disclosures The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.